doi: 10.1681/ASN.2005101040 7 ClissoldRLHamiltonAJHattersleyATEllardSBinghamC
Therefore, current scientific evidence consistently indicates that, after achieving clinically significant weight reduction, people living with overweight or obesity should continue pharmacological treatment at the maximum tolerated dose to avoid the expected and demonstrated weight regain
J Inherit Metab Dis 45:183191
Those patients who have a fixed income are going to be our more vulnerable patients, Addison said
So, If you were on lower Mounjaro doses (2.5mg5mg), youll typically start Wegovy at 0.25mg0.5mg If you were on mid-range doses (7.5mg10mg), a starting point of 0.5mg1mg is more common If you were on higher doses (12.5mg15mg), your prescriber may consider starting at 1mg, though this is always an individual clinical decision As we said earlier, this isnt a step backwards